As Lipedema Awareness Month unfolds this June, Dr. Iakovos Georgiou, MD, Director of Plastic Surgery at the German Medical Institute, joins a growing global effort to shed light on this often misunderstood and underdiagnosed disorder. Recognised in advanced lipedema care and surgical interventions, Dr. Georgiou remains committed to elevating awareness, improving patient outcomes, and advancing the international conversation surrounding lipedema.

Lipedema is a chronic and progressive fat disorder, primarily affecting women, that is frequently misdiagnosed as simple obesity or lymphedema. Despite its significant physical and emotional toll, it remains widely underrecognized in both public and clinical settings. June, the Lipedema Awareness Month, provides a crucial opportunity to educate, advocate, and inspire action.

As part of his ongoing advocacy and clinical leadership, Dr. Georgiou will be delivering three international presentations on lipedema throughout the month, two of which will be featured at the International Society of Aesthetic Plastic Surgery (ISAPS) Olympiad in Singapore. These sessions will cover advanced surgical techniques, comprehensive treatment approaches, and setting up an international lipedema center. His participation in such high-profile academic events highlights not only the increasing importance of lipedema within the field of plastic surgery but also the global reach of Dr. Georgiou’s expertise.

“Every patient with lipedema deserves access to compassionate, evidence-based care,” says Dr. Georgiou. “Raising awareness is not just about recognition, it’s about reshaping how we treat this condition from diagnosis to recovery.”

At the German Medical Institute, Dr. Georgiou leads a multidisciplinary team dedicated to treating lipedema with precision and empathy. His integrated approach combines surgical excellence with ongoing research and patient education, setting new standards in both technique and care delivery. During this month of awareness, Dr. Georgiou encourages patients, healthcare professionals, and policy advocates to unite in support of early diagnosis, greater public understanding, and expanded access to effective treatments for lipedema worldwide.